Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Gevaert

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Allergy|July 16, 2019
Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposisClaus Bachert, Peter W Hellings, Joaquim Mullol, et al.
Laryngoscope Investigative Otolaryngology|May 28, 2024
Assessment of chronic rhinosinusitis with nasal polyps: Development of the Nasal Polyp Patient Assessment Scoring Sheet toolSaad Alsaleh, Nehal Kamal, Claire Hopkins, et al.
The World Allergy Organization Journal|October 31, 2025
Improvement of the therapeutic management of allergic patients in Europe - An expert think tank's position paper on allergen immunotherapyOliver Pfaar, Maria Beatrice Bilò, Péter Csonka, et al.
Allergy|June 8, 2024
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposisClaus Bachert, Philippe Gevaert, Brian Lipworth, et al.
JAMA|February 3, 2016
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical TrialClaus Bachert, Leda Mannent, Robert M Naclerio, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trialEugenio De Corso, G Walter Canonica, Enrico Heffler, et al.
Allergy|October 19, 2020
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperLudger Klimek, Marek Jutel, Jean Bousquet, et al.
Allergy|February 6, 2026
Comorbid Chronic Rhinosinusitis and Asthma: Shared Risk Factors and Treatment Implications-An EAACI Task Force ReportSanna Toppila-Salmi, Sietze Reitsma, Valérie Hox, et al.
International Forum of Allergy & Rhinology|February 10, 2025
Expert Consensus on Surgical Management of Primary Diffuse Type 2-Dominant Chronic RhinosinusitisManon Blauwblomme, Christos Georgalas, Shahzada Ahmed, et al.
Allergy|January 20, 2023
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisPhilippe Gevaert, Jarno De Craemer, Claus Bachert, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Allergy|July 16, 2019
Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposisClaus Bachert, Peter W Hellings, Joaquim Mullol, et al.
Laryngoscope Investigative Otolaryngology|May 28, 2024
Assessment of chronic rhinosinusitis with nasal polyps: Development of the Nasal Polyp Patient Assessment Scoring Sheet toolSaad Alsaleh, Nehal Kamal, Claire Hopkins, et al.
The World Allergy Organization Journal|October 31, 2025
Improvement of the therapeutic management of allergic patients in Europe - An expert think tank's position paper on allergen immunotherapyOliver Pfaar, Maria Beatrice Bilò, Péter Csonka, et al.
Allergy|June 8, 2024
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposisClaus Bachert, Philippe Gevaert, Brian Lipworth, et al.
JAMA|February 3, 2016
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical TrialClaus Bachert, Leda Mannent, Robert M Naclerio, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trialEugenio De Corso, G Walter Canonica, Enrico Heffler, et al.
Allergy|October 19, 2020
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperLudger Klimek, Marek Jutel, Jean Bousquet, et al.
Allergy|February 6, 2026
Comorbid Chronic Rhinosinusitis and Asthma: Shared Risk Factors and Treatment Implications-An EAACI Task Force ReportSanna Toppila-Salmi, Sietze Reitsma, Valérie Hox, et al.
International Forum of Allergy & Rhinology|February 10, 2025
Expert Consensus on Surgical Management of Primary Diffuse Type 2-Dominant Chronic RhinosinusitisManon Blauwblomme, Christos Georgalas, Shahzada Ahmed, et al.
Allergy|January 20, 2023
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisPhilippe Gevaert, Jarno De Craemer, Claus Bachert, et al.
Pageof 15